Loading clinical trials...
Loading clinical trials...
This is a Phase 1/2a, open-label study to evaluate the safety, tolerability, immunogenicity, and preliminary clinical activity of RZ-001 administered in combination with VGCV in subjects with hTERT-po...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rznomics, Inc.
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT07003542 · Glioblastoma, Brain Tumor
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT07274397 · Glioblastoma, Brain Tumors, and more
The Catholic University of Korea, Incheon St. Mary's Hospital
Incheon
Gachon University Gil Medical Center
Incheon
Seoul National University Bundang Hospital
Seongnam-si
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions